ARCHIVES

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

This article is from The Cancer Letter archive.

Vol. 06 No. 45 | November 14, 1980

Download PDF Visit The Full Archive

Related Articles

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993

NCI Research Grant Funding To Exceed $1.5 Billion, Support 4,800 Grants, In FY00.

January 14, 2000

No Issue Next Week

August 22, 1980

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995